Selected publications
-
Adjuvant Vascular Endothelial Growth Factor–targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis [Figure presented].
European Urology.
2018
Review
GET IT
Times cited: 19 -
Pazopanib exposure relationship with clinical efficacy and safety in the adjuvant treatment of advanced renal cell carcinoma.
Clinical Cancer Research.
2018
Academic Article
GET IT
Times cited: 21 -
Randomized phase III trial of adjuvant pazopanib versus placebo after nephrectomy in patients with localized or locally advanced renal cell carcinoma.
Journal of Clinical Oncology.
2017
Academic Article
GET IT
Times cited: 133 -
A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802.
Medical Oncology.
2012
Academic Article
GET IT
Times cited: 80 -
Melanoma: Clinical practice guidelines in oncology™.
JNCCN Journal of the National Comprehensive Cancer Network.
2006
Review
GET IT
Times cited: 25